Myeloperoxidase Antibody, IgG
Protein S Total, Antigen
Biopsy, Testicular
B-Type Natriuretic Peptide (BNP) or Pro B-Type Natriuretic Peptide (Pro BNP)
Digoxin, Free, Serum
MAML2 (11q21) Rearrangement, Mucoepidermoid Carcinoma (MEC), FISH, Tissue
Small Nuclear Ribonucleoprotein Polypeptide N and Ubiquitin Protein Ligase E3A (SNRPN/UBE3A) Methylation Analysis
Myelin Associated Glycoprotein (MAG) Antibody
Cholesterol, Serum/Plasma
Selenium, 24 Hour, Urine

LDS
Sign up
Log in

LDS
/Medical Tests
/EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay)

All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References

All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References

EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay)
Medical Test

Access to EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay) is restricted.